These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26283642)

  • 1. Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction.
    Prossin AR; Koch AE; Campbell PL; Barichello T; Zalcman SS; Zubieta JK
    Mol Psychiatry; 2016 Feb; 21(2):243-51. PubMed ID: 26283642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers.
    Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK
    Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
    Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK
    Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
    Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
    JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation.
    Piché M; Watanabe N; Sakata M; Oda K; Toyohara J; Ishii K; Ishiwata K; Hotta H
    Neurosci Res; 2014; 81-82():78-84. PubMed ID: 24583336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Top-Down" Mu-Opioid System Function in Humans: Mu-Opioid Receptors in Ventrolateral Prefrontal Cortex Mediate the Relationship Between Hedonic Tone and Executive Function in Major Depressive Disorder.
    Light SN; Bieliauskas LA; Zubieta JK
    J Neuropsychiatry Clin Neurosci; 2017; 29(4):357-364. PubMed ID: 28412878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of regional endogenous opioid function in borderline personality disorder.
    Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR
    Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder.
    Al-Fadhel SZ; Al-Hakeim HK; Al-Dujaili AH; Maes M
    Eur Psychiatry; 2019 Apr; 57():46-51. PubMed ID: 30677547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain.
    Strigo IA; Simmons AN; Matthews SC; Craig AD; Paulus MP
    Arch Gen Psychiatry; 2008 Nov; 65(11):1275-84. PubMed ID: 18981339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
    Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.